Marshall Wace, LLP Maravai Lifesciences Holdings, Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 2,778,497 shares of MRVI stock, worth $11.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,778,497
Previous 15,425
17912.95%
Holding current value
$11.4 Million
Previous $128,000
11729.69%
% of portfolio
0.02%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding MRVI
# of Institutions
210Shares Held
139MCall Options Held
237KPut Options Held
19.4K-
Gtcr LLC20.2MShares$83 Million10.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$48.7 Million0.0% of portfolio
-
12 West Capital Management LP New York, NY11.6MShares$47.8 Million6.99% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$40.1 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$34.4 Million1.97% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $542M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...